Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
0.6274
-0.5076 (-44.72%)
Oct 7, 2026, 12:16 PM EDT - Market open
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $67.26 million as of October 7, 2026. Its market cap has decreased by -69.13% in one year.
Market Cap
67.26M
Enterprise Value
-19.90M
1-Year Change
-69.13%
Ranking
Category
Stock Price
$0.63
ChartMarket Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $67.26M, a decrease of -92.43%. That is a compound annual growth rate of -39.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 67.26M | -54.74% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 124.27M |
| Spruce Biosciences | 122.96M |
| Tenaya Therapeutics | 122.54M |
| PMV Pharmaceuticals | 121.58M |
| Seer, Inc. | 121.26M |
| enGene Therapeutics | 120.63M |
| Cibus | 119.99M |
| LENZ Therapeutics | 119.08M |